University of Alabama at Birmingham: Lymphoma trials

The registry lists 12 Lymphoma studies with University of Alabama at Birmingham as lead sponsor. 1 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 6Phase 2 5Phase 3 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic LymphohistiocytosisRecruitingNCT05898477
• Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell TherapyCompletedNCT04975555Phase 2Results posted
• Clinical Trial of Ublituximab and Umbralisib With CHOP (U2-CHOP) Followed by U2 Maintenance (U2-CHOP-U2) in Previously Untreated Mantle Cell Lymphoma (MCL)TerminatedNCT04692155Phase 1/2Results posted
• Post Transplant Cyclophosphamide (Cytoxan) for GvHD ProphylaxisCompletedNCT02065154Phase 2Results posted
• Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell MalignanciesTerminatedNCT00714259Phase 2/3Results posted
• PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCLWithdrawnNCT06290622Phase 1
• Study of Tazemetostat in Lymphoid MalignanciesTerminatedNCT05983965Phase 1
• Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell LymphomasTerminatedNCT00704691Early Phase 1
• Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00033423Phase 1
• Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00005592Phase 2
• Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's LymphomaCompletedNCT00004162Phase 1
• Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ TransplantsWithdrawnNCT00002956Phase 1